Agilent Technologies EBIT Margin 2010-2024 | A
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Agilent Technologies (A) over the last 10 years. The current EBIT profit margin for Agilent Technologies as of January 31, 2024 is .
| Agilent Technologies EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2024-01-31 |
$6.74B |
$1.31B |
19.42% |
| 2023-10-31 |
$6.83B |
$1.35B |
19.76% |
| 2023-07-31 |
$6.99B |
$1.41B |
20.20% |
| 2023-04-30 |
$7.04B |
$1.69B |
24.02% |
| 2023-01-31 |
$6.93B |
$1.67B |
24.07% |
| 2022-10-31 |
$6.85B |
$1.62B |
23.63% |
| 2022-07-31 |
$6.66B |
$1.54B |
23.16% |
| 2022-04-30 |
$6.53B |
$1.47B |
22.48% |
| 2022-01-31 |
$6.45B |
$1.40B |
21.64% |
| 2021-10-31 |
$6.32B |
$1.35B |
21.32% |
| 2021-07-31 |
$6.14B |
$1.25B |
20.37% |
| 2021-04-30 |
$5.82B |
$1.15B |
19.68% |
| 2021-01-31 |
$5.53B |
$0.96B |
17.34% |
| 2020-10-31 |
$5.34B |
$0.85B |
15.85% |
| 2020-07-31 |
$5.22B |
$0.80B |
15.26% |
| 2020-04-30 |
$5.24B |
$0.79B |
15.13% |
| 2020-01-31 |
$5.24B |
$0.91B |
17.30% |
| 2019-10-31 |
$5.16B |
$0.94B |
18.23% |
| 2019-07-31 |
$5.09B |
$0.94B |
18.37% |
| 2019-04-30 |
$5.02B |
$0.93B |
18.55% |
| 2019-01-31 |
$4.99B |
$0.93B |
18.55% |
| 2018-10-31 |
$4.91B |
$0.90B |
18.40% |
| 2018-07-31 |
$4.81B |
$0.86B |
17.86% |
| 2018-04-30 |
$4.72B |
$0.84B |
17.78% |
| 2018-01-31 |
$4.62B |
$0.83B |
17.98% |
| 2017-10-31 |
$4.47B |
$0.81B |
18.05% |
| 2017-07-31 |
$4.39B |
$0.79B |
18.00% |
| 2017-04-30 |
$4.32B |
$0.74B |
17.02% |
| 2017-01-31 |
$4.24B |
$0.67B |
15.70% |
| 2016-10-31 |
$4.20B |
$0.62B |
14.64% |
| 2016-07-31 |
$4.13B |
$0.59B |
14.25% |
| 2016-04-30 |
$4.10B |
$0.59B |
14.31% |
| 2016-01-31 |
$4.04B |
$0.56B |
13.91% |
| 2015-10-31 |
$4.04B |
$0.52B |
12.93% |
| 2015-07-31 |
$4.81B |
$0.54B |
11.23% |
| 2015-04-30 |
$4.80B |
$0.53B |
10.97% |
| 2015-01-31 |
$4.83B |
$0.51B |
10.65% |
| 2014-10-31 |
$4.81B |
$0.52B |
10.87% |
| 2014-07-31 |
$4.72B |
$0.63B |
13.42% |
| 2014-04-30 |
$5.37B |
$0.74B |
13.77% |
| 2014-01-31 |
$6.11B |
$0.86B |
14.04% |
| 2013-10-31 |
$6.78B |
$0.95B |
14.02% |
| 2013-07-31 |
$6.83B |
$0.94B |
13.82% |
| 2013-04-30 |
$6.90B |
$0.98B |
14.17% |
| 2013-01-31 |
$6.90B |
$1.07B |
15.43% |
| 2012-10-31 |
$6.86B |
$1.12B |
16.32% |
| 2012-07-31 |
$6.82B |
$1.15B |
16.92% |
| 2012-04-30 |
$6.79B |
$1.17B |
17.17% |
| 2012-01-31 |
$6.73B |
$1.13B |
16.80% |
| 2011-10-31 |
$6.62B |
$1.07B |
16.19% |
| 2011-07-31 |
$6.46B |
$0.96B |
14.87% |
| 2011-04-30 |
$6.16B |
$0.80B |
12.91% |
| 2011-01-31 |
$5.75B |
$0.68B |
11.88% |
| 2010-10-31 |
$5.44B |
$0.57B |
10.40% |
| 2010-07-31 |
$5.04B |
$0.43B |
8.62% |
| 2010-04-30 |
$4.71B |
$0.32B |
6.75% |
| 2010-01-31 |
$4.53B |
$0.12B |
2.58% |
| 2009-10-31 |
$4.48B |
$0.05B |
1.05% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Electrical Test Equipment |
$40.292B |
$6.833B |
|
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|
